Gastroesophageal Reflux Disease Management

Introduction

Gastroesophageal reflux disease (GERD) is a physiologic process controlled by protective factors, including the crural diaphragm and intra-abdominal to intra-thoracic pressure gradient, as explained by the American Gastroenterological Association 1

The American Gastroenterological Association recommends taking proton pump inhibitors (PPIs) 30-60 minutes before meals for optimal effect 1
Implementing stress-reducing activities such as mindfulness is recommended for patients with GERD, as suggested by the American Gastroenterological Association 1
Elevating the head of bed by 6-8 inches and sleeping in the left lateral decubitus position are advised to reduce GERD symptoms, as recommended by the American College of Gastroenterology and the American Thoracic Society 2, 3
Twice-daily PPI therapy is strongly recommended as the initial management for patients with severe GERD, after cardiac causes have been carefully excluded, according to the American Gastroenterological Association 4

Adapt food texture to facilitate swallowing and avoid aspiration, with soft, semisolid, or semiliquid foods for patients with difficulty swallowing, and thicker liquids or semisolid foods with high water content for delayed swallowing, as recommended by 5
Fractionate meals into smaller, more frequent portions to reduce symptoms, as suggested by 5
Meal enrichment with high-calorie foods may be beneficial for patients with muscular fatigue and long-lasting meals, as recommended by 5
Limit daily fat intake to less than 45g to reduce GERD symptoms, as suggested by the American College of Chest Physicians and the American College of Gastroenterology 6, 3, 2
Avoid trigger foods and drinks, such as coffee, tea, chocolate, mints, citrus, tomatoes, spicy foods, and alcohol, as recommended by the American College of Gastroenterology and the American Thoracic Society 2, 3

Provide standardized educational materials on GERD mechanisms, weight management strategies, lifestyle and dietary modifications, relaxation techniques, and brain-gut axis relationship, as recommended by the American Gastroenterological Association 1
Weight loss is strongly recommended for overweight or obese patients with GERD, as it is considered first-line non-pharmacological therapy, and should be implemented alongside appropriate medical therapy for optimal management, as recommended by the American Gastroenterological Association 1

Empiric PPI trial is not optimal for isolated extra-esophageal symptoms, as mechanisms other than GERD frequently contribute to symptom generation, as recommended by the American Gastroenterological Association 1
For patients presenting with symptoms suggestive of GERD, a 4-8 week trial of once-daily proton pump inhibitor (PPI) therapy is the recommended initial management approach, provided no alarm symptoms are present, as recommended by the American Gastroenterological Association 1, 4
The following table summarizes the guidelines for diagnostic testing:

Test	Indication	Recommendation
Upper endoscopy	Persistent symptoms despite PPI therapy	American College of Physicians [7]
Esophageal manometry	Confirm diagnosis of esophageal spasm	American Gastroenterological Association [4]
pH or impedance-pH monitoring	Persistent symptoms	European Society of Gastrointestinal Motility [8]

Conclusive GERD evidence is defined as erosive esophagitis of Los Angeles Grade B or higher, and/or acid exposure time (AET) ≥6.0% on 2 or more days, as recommended by the American Gastroenterological Association 1

Proton pump inhibitors (PPIs) are the most effective medication class for GERD treatment, with standard options including omeprazole (20-40mg), lansoprazole (15-30mg), esomeprazole (20-40mg), and rabeprazole (20mg), as recommended by the American Gastroenterological Association 9
Twice daily PPI is superior to once daily PPI in gastric acid suppression and likely more effective for symptoms, according to the American Gastroenterological Association 2
Alginate-containing antacids may provide additional benefit when added to PPI therapy, according to the American College of Gastroenterology 2
H2-receptor antagonists are an alternative option for mild symptoms, but may develop tachyphylaxis within 6 weeks, as recommended by the American Academy of Family Physicians 10
Laparoscopic fundoplication is recommended only in patients with objectively documented gastroesophageal reflux, as suggested by the Society of American Gastrointestinal and Endoscopic Surgeons 9
Magnetic sphincter augmentation is an emerging less invasive option for GERD treatment, as suggested by the American Gastroenterological Association 2

For infants with GERD, first-line treatments include modifying maternal diet in breastfed infants, changing formula in formula-fed infants, reducing feeding volume while increasing feeding frequency, and considering thickening formula (except in preterm infants due to risk of necrotizing enterocolitis), as recommended by the American Academy of Family Physicians 10
Esomeprazole is recommended for infants 1-12 months with GERD and erosive esophagitis, as recommended by the American Academy of Pediatrics 11
In pregnancy, the recommended first-line approach is lifestyle and dietary modifications, followed by a step-up medication approach starting with antacids, then sucralfate, H2-receptor antagonists, and finally proton pump inhibitors for refractory cases, as recommended by the American Gastroenterological Association and ACOG 12

Long-term PPI therapy requires periodic reassessment for appropriate use and potential adverse effects, and patients should be evaluated for objective confirmation of GERD if PPI therapy is continued beyond 12 months, with surveillance endoscopy continued every 3-5 years if intestinal metaplasia persists without dysplasia, as recommended by the American Gastroenterological Association 1, 4, 13
Personalize treatment based on symptom pattern, using alginate antacids for breakthrough symptoms, nighttime H2-receptor antagonists for nocturnal symptoms, baclofen for regurgitation or belch-predominant symptoms, and prokinetics for coexistent gastroparesis, as recommended by the American Gastroenterological Association 1
Shared decision-making between patient, gastroenterologist, and surgeon is essential for determining the best course of treatment, including surgery, as recommended by the American Gastroenterological Association 2